Guide to using GLP-1RAs for T2D in primary care – Your questions answered

   Rated 0 / 5 stars

CPD for this activity

Educational Activities (EA)
60 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)
30 minutes

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)
0 minutes

These are activities that use your work data to ensure quality results.

EA
60 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
30 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

  1. How to administer GLP1Ras? Dosing and titration?
  2. What are the differences with the current weekly GLP1RAS?
  3. How should the injections be stored?
  4. When to start? Who would benefit the most? Who should it NOT be used in?
  5. How do you manage the GI side effects?
  6. Duration of treatment?
  7. Are there any drug interactions?
  8. Choice of therapy after metformin
  9. Under PBS what other OHA can they be used with?
  10. Can they be used for people with T2DM with an HbA1c <7%?
  11. What are the TGA approved use of GLP1RAs?
  12. GLP1RAs – Are there any CVD benefits (IHD and CCF)? Renal benefits?
  13. Clarify why DPP4i and GLP1RA shouldn’t be used together
  14. What would make you stop a GLP1RA? What happens when you stop GLP1RAs?
  15. Do people develop a tolerance to GLP1RAs?
  16. Are they safe for long term use?
  17. Why is there an increase in retinopathy and cholelithiasis?
  18. What tests should be done before starting a GLP1RA? (tests of pancreas, thyroid us, eye screen, gall bladder?
  19. Should patients have their lipase monitored?
  20. If someone has a history of pancreatitis can they use GLP1RAs?
  21. If there is a history of thyroid cancer, can a GLP1RA be used?
  22. Compliance – is there any data on cessation or how long people stay on the medication in the real world?
  23. Is the compounded semaglutide safe?
  24. Is fatigue a common side effect? If you have GI side effects that persist is it worth changing brand?
  25. Off label prescribing – what protections do we have?
  26. How long to stop GLP1RAs before conception? If conceives whilst on these medications what does it mean for the foetus?
  27. Does it burn out the pancreas?
  28. How do they work? How effective are they?
  29. How many people do not respond and why?
  30. A stack of questions on availability?

Guest: Facilitator A/Prof Ralph Audehm, General Practitioner
Panelists Dr Richard MacIsaac, Endocrinologist & Prof Richard O’Brien, Endocrinologist

Host: Dr David Lim, GP and Medical Educator

Total time: 55 mins

Last Updated: 5 Oct, 2023

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

GLP-1 Prescribing Expert Panel Discussion

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Arrhythmia Management in Primary Care

Dr Rupert Hinds

Dr Rupert Hinds

Infant Allergy Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Ralph Audehm

expert

A/Prof Ralph Audehm

General Practitioner; Carlton Family Medical, Melbourne; Clinical Associate Professor, University of Melbourne, Department of General Practice

Prof Richard O'Brien

expert

Prof Richard O'Brien

Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health

Prof Richard MacIsaac

expert

Prof Richard MacIsaac

Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.